03/26/2025
8:57 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
3:35 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4/A | |
03/20/2025
3:35 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:36 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:12 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:28 PM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
3:29 PM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
3:29 PM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:29 PM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
3:29 PM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CADL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/13/2025
3:45 PM | Candel Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
12:35 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:32 PM | Candel Therapeutics (Subject)
Northpond Ventures, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:30 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:25 AM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:09 PM | Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:18 AM | Candel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:03 AM | Candel Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
7:30 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
7:05 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
3:30 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:27 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:27 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:28 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:28 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:29 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
6:37 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Claim Your FREE Protection Guide (Ad) In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code...
And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos.
But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition... Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now → |
12/26/2024
12:59 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:11 PM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
11:30 AM | Candel Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SC 13G | |
12/13/2024
5:12 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:30 PM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
3:36 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/12/2024
3:55 PM | Candel Therapeutics (Filer)
| Form 424B5 | |
12/11/2024
6:45 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
5:44 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:46 PM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:47 PM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:48 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:48 PM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
8:12 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:13 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:15 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
8:17 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:24 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
2:07 PM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:58 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
5:08 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
5:41 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:59 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:19 PM | Aguilar Laura K. (Reporting)
Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:16 PM | Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:53 PM | Aguilar-Cordova Estuardo (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:15 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:30 AM | Candel Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
7:26 AM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:28 AM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:29 AM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:31 AM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
7:24 AM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
6:28 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:29 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:31 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:32 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:27 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:32 AM | Candel Therapeutics (Issuer)
Nichols William Garrett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:34 AM | Candel Therapeutics (Issuer)
Schoch Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:35 AM | Candel Therapeutics (Issuer)
Tak Paul Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:36 AM | Candel Therapeutics (Issuer)
Tyagarajan Seshu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
7:30 AM | Barone Francesca (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
6:33 AM | Barone Francesca (Reporting)
Candel Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
6:35 AM | Candel Therapeutics (Subject)
Nichols William Garrett (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
6:36 AM | Candel Therapeutics (Subject)
Schoch Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
6:37 AM | Candel Therapeutics (Subject)
Tak Paul Peter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Trump Orders 'National Digital Asset Stockpile' (Ad) ‘Digital Asset Reserve’ for THIS Coin???
Get all the details before this story gains even more traction SHOW ME THE #1 CRYPTO TO OWN RIGHT NOW |
07/11/2024
6:38 AM | Candel Therapeutics (Subject)
Tyagarajan Seshu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
7:39 AM | Candel Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
7:40 AM | Candel Therapeutics (Issuer)
Nguyen Diem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
7:41 AM | Candel Therapeutics (Issuer)
PAPA JOSEPH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
7:34 AM | Benz Edward J. JR (Reporting)
Candel Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
7:35 AM | Candel Therapeutics (Issuer)
Gaeta Renee (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
7:36 AM | Candel Therapeutics (Issuer)
Loggia Nicoletta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
7:37 AM | Candel Therapeutics (Issuer)
Manning Paul B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
7:39 AM | Candel Therapeutics (Issuer)
Martell Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy CADL Stock Free CADL Stock Alerts